MAPT and Alzheimer disease: For example, DBS may regulate the microenvironment of AD animal models by promoting ACh release, inducing NGF synthesis, and reducing Aβ and tau levels (Hescham et al., 2013a; Xia et al., 2017; Huang et al., 2019).